Evidence map›Paper›PMID 24768588›Full record

ArticleExperimental and molecular pathology2014

Gene expression profiles in granuloma tissue reveal novel diagnostic markers in sarcoidosis.

George P Christophi, Tiffany Caza, Christopher Curtiss, Divya Gumber, Paul T Massa, Steve K Landas

Open access · greenAbstract read
In one paragraph

Article in Experimental and molecular pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Scoping out sarcoidosis: the evolving role of bronchoscopy.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Offense and Defense in Granulomatous Inflammation Disease.Frontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

George P ChristophiDepartment of Gastroenterology, Washington University School of Medicine, St. Louis, MO, United States. Electronic address: gchristo@dom.wustl.edu.
Tiffany CazaDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
Christopher CurtissDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
Divya GumberDepartment of Internal Medicine, Cleveland Clinic, Cleveland, OH, United States.
Paul T MassaDepartment of Microbiology & Immunology, SUNY Upstate Medical University, Syracuse, NY, United States.
Steve K LandasDepartment of Pathology, SUNY Upstate Medical University, Syracuse, NY, United States.
SUNY Upstate Medical University · USCleveland Clinic · USWashington University in St. Louis · US

Funding

REGULATION OF INTERFERON ACTIVITY BY SHP-1 IN THE CNSR01NS041593 · NINDS · UPSTATE MEDICAL UNIVERSITY · PI MASSA, PAUL T · 2001 to 2007
$1.2M
NINDS NIH HHS NS041593NINDS NIH HHS R01 NS041593
6 · The paper itself

Abstract

Sarcoidosis is an immune-mediated multisystem disease characterized by the formation of non-caseating granulomas. The pathogenesis of sarcoidosis is unclear, with proposed infectious or environmental antigens triggering an aberrant immune response in susceptible hosts. Multiple pro-inflammatory signaling pathways have been implicated in mediating macrophage activation and granuloma formation in sarcoidosis, including IFN-γ/STAT-1, IL-6/STAT-3, and NF-κB. It is difficult to distinguish sarcoidosis from other granulomatous diseases or assess disease severity and treatment response with histopathology alone. Therefore, development of improved diagnostic tools is imperative. Herein, we describe an efficient and reliable technique to classify granulomatous disease through selected gene expression and identify novel genes and cytokine pathways contributing to the pathogenesis of sarcoidosis. We quantified the expression of twenty selected mRNAs extracted from formalin-fixed paraffin embedded (FFPE) tissue (n = 38) of normal lung, suture granulomas, sarcoid granulomas, and fungal granulomas. Utilizing quantitative real-time RT-PCR we analyzed the expression of several genes, including IL-6, COX-2, MCP-1, IFN-γ, T-bet, IRF-1, Nox2, IL-33, and eotaxin-1 and revealed differential regulation between suture, sarcoidosis, and fungal granulomas. This is the first study demonstrating that quantification of target gene expression in FFPE tissue biopsies is a potentially effective diagnostic and research tool in sarcoidosis.

Indexed as

Genetic MarkersTranscriptomeAdolescentAdultAgedAged, 80 and overChemokine CCL11Chemokine CCL2ChildCyclooxygenase 2FemaleGene ExpressionGranulomaHumansInterferon-gammaInterleukin-33CCL11 protein, humanCCL2 protein, humanChemokine CCL11Chemokine CCL2CYBB protein, humanCyclooxygenase 2Genetic MarkersIL33 protein, humanInterferon-gammaInterleukin-33Interleukin-6InterleukinsMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesNF-kappa BPTGS2 protein, humanSTAT1 protein, humanSTAT1 Transcription FactorSTAT3 protein, humanSTAT3 Transcription FactorCytokinesFormalin-fixed paraffin embedded tissueGene expressionGranulomaPathology autoimmunityReactive oxygen speciesRT-PCRSarcoidosisTranscription factor

Identifiers

PMID24768588
PMCPMC4048782
OpenAlexW2067976649

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.